Among the many rife regulatory pro...

Among the many rife regulatory projects in Europe upon medicines development, one that has lain fallow for a year or in such a manner is now emerging again into the limelight--the promotion of clinical trials upon pediatric medicines. But progres is moderate enough to bring to mind the child who the melancholy Jacques describes "with satchel and shining morning face, creeping like snail unwillingly to school" (1) There has still been no satiated discussion in the European Union about to what extent to turn the idea into a reality. Instead, the latest instigate is that the EU has announced plans "to